|
chr9_+_92219926
|
1.139
|
NM_006705
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
|
chr10_-_98592186
|
1.130
|
|
|
|
|
chr17_+_79989485
|
1.099
|
NM_005052
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
chr6_+_36098261
|
1.030
|
NM_002754
|
MAPK13
|
mitogen-activated protein kinase 13
|
|
chr20_-_31172874
|
0.899
|
|
LOC284804
|
uncharacterized LOC284804
|
|
chr1_-_935469
|
0.788
|
NM_001142467
NM_021170
|
HES4
|
hairy and enhancer of split 4 (Drosophila)
|
|
chrX_-_154688260
|
0.763
|
NM_001007523
NM_001007524
NM_012151
|
F8A2
F8A3
F8A1
|
coagulation factor VIII-associated 2
coagulation factor VIII-associated 3
coagulation factor VIII-associated 1
|
|
chr2_-_97760544
|
0.756
|
NM_199336
|
FAHD2B
|
fumarylacetoacetate hydrolase domain containing 2B
|
|
chr20_-_633808
|
0.704
|
|
SRXN1
|
sulfiredoxin 1
|
|
chr1_-_935352
|
0.678
|
|
HES4
|
hairy and enhancer of split 4 (Drosophila)
|
|
chr17_+_16318848
|
0.665
|
NM_016113
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
chr3_+_67705120
|
0.662
|
|
|
|
|
chr15_-_75135429
|
0.642
|
|
ULK3
|
unc-51-like kinase 3 (C. elegans)
|
|
chr9_+_140145712
|
0.637
|
NM_001004353
|
C9orf173
|
chromosome 9 open reading frame 173
|
|
chr20_-_633844
|
0.633
|
NM_080725
|
SRXN1
|
sulfiredoxin 1
|
|
chr15_-_75135480
|
0.629
|
|
ULK3
|
unc-51-like kinase 3 (C. elegans)
|
|
chr2_-_211090146
|
0.620
|
NM_001608
|
ACADL
|
acyl-CoA dehydrogenase, long chain
|
|
chr1_+_207495009
|
0.618
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
chr11_-_61684981
|
0.616
|
NM_013401
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1
|
|
chr4_+_84457390
|
0.615
|
NM_032717
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9
|
|
chr19_-_19738973
|
0.614
|
NM_004720
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
chr19_-_10679328
|
0.614
|
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
|
|
chr1_+_207494816
|
0.612
|
NM_000574
NM_001114752
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
chr6_-_31550065
|
0.608
|
NM_002341
NM_009588
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
|
chr20_+_42984088
|
0.598
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
chr3_-_45267620
|
0.585
|
|
TMEM158
|
transmembrane protein 158 (gene/pseudogene)
|
|
chr4_+_39529551
|
0.576
|
|
|
|
|
chrX_+_154114609
|
0.573
|
NM_001007523
NM_001007524
NM_012151
|
F8A2
F8A3
F8A1
|
coagulation factor VIII-associated 2
coagulation factor VIII-associated 3
coagulation factor VIII-associated 1
|
|
chr2_+_71680752
|
0.570
|
NM_001130976
NM_001130977
NM_001130978
NM_001130979
NM_001130980
NM_001130981
NM_003494
|
DYSF
|
dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive)
|
|
chr17_+_59533806
|
0.569
|
NM_018488
|
TBX4
|
T-box 4
|
|
chr1_+_19934573
|
0.563
|
|
|
|
|
chr5_-_108063960
|
0.553
|
|
HP07349
|
uncharacterized protein HP07349
|
|
chr11_-_65337743
|
0.545
|
|
LOC254100
|
uncharacterized LOC254100
|
|
chr1_+_207495086
|
0.533
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
chr17_-_17399494
|
0.524
|
NM_001199989
NM_016084
|
RASD1
|
RAS, dexamethasone-induced 1
|
|
chr2_-_230933618
|
0.516
|
NM_152527
|
SLC16A14
|
solute carrier family 16, member 14 (monocarboxylic acid transporter 14)
|
|
chr2_+_121103670
|
0.511
|
NM_002193
|
INHBB
|
inhibin, beta B
|
|
chr17_+_77893155
|
0.501
|
|
|
|
|
chr11_+_35160832
|
0.492
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
chr11_-_74442185
|
0.490
|
NM_015424
|
CHRDL2
|
chordin-like 2
|
|
chr2_-_27718059
|
0.485
|
|
FNDC4
|
fibronectin type III domain containing 4
|
|
chr9_+_126774028
|
0.475
|
|
LHX2
|
LIM homeobox 2
|
|
chr1_-_153508597
|
0.475
|
NM_014624
|
S100A6
|
S100 calcium binding protein A6
|
|
chr11_+_130029773
|
0.465
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
chr20_+_2276612
|
0.462
|
NM_003245
|
TGM3
|
transglutaminase 3 (E polypeptide, protein-glutamine-gamma-glutamyltransferase)
|
|
chr7_+_75831194
|
0.461
|
NM_001110199
|
SRRM3
|
serine/arginine repetitive matrix 3
|
|
chr4_+_84457256
|
0.454
|
|
AGPAT9
|
1-acylglycerol-3-phosphate O-acyltransferase 9
|
|
chr17_-_73874634
|
0.453
|
NM_033452
|
TRIM47
|
tripartite motif containing 47
|
|
chr4_+_154265774
|
0.451
|
NM_001253861
NM_032117
|
MND1
|
meiotic nuclear divisions 1 homolog (S. cerevisiae)
|
|
chr5_+_175792444
|
0.448
|
NM_173664
|
ARL10
|
ADP-ribosylation factor-like 10
|
|
chr5_+_179234002
|
0.446
|
NM_001142299
|
SQSTM1
|
sequestosome 1
|
|
chr7_-_559030
|
0.446
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
chr10_+_104155431
|
0.444
|
NM_002502
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
chr11_+_72975569
|
0.443
|
NM_176796
NM_176797
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
chr9_+_36136710
|
0.425
|
NM_022343
|
GLIPR2
|
GLI pathogenesis-related 2
|
|
chr19_-_3606566
|
0.425
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
chr2_-_71062904
|
0.417
|
NM_015717
|
CD207
|
CD207 molecule, langerin
|
|
chr1_-_153508495
|
0.415
|
|
S100A6
|
S100 calcium binding protein A6
|
|
chr3_-_71803923
|
0.413
|
NM_173359
|
EIF4E3
|
eukaryotic translation initiation factor 4E family member 3
|
|
chr14_-_65879245
|
0.413
|
|
LOC645431
|
uncharacterized LOC645431
|
|
chr17_+_48638339
|
0.405
|
NM_018896
NM_198376
NM_198377
NM_198378
NM_198379
NM_198380
NM_198382
NM_198383
NM_198384
NM_198385
NM_198386
NM_198387
NM_198388
NM_198396
NM_198397
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
chr2_-_96810775
|
0.402
|
|
DUSP2
|
dual specificity phosphatase 2
|
|
chr12_-_51785192
|
0.395
|
NM_007210
|
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)
|
|
chr11_+_65554566
|
0.394
|
|
OVOL1
|
ovo-like 1(Drosophila)
|
|
chr1_+_46269283
|
0.393
|
NM_015112
|
MAST2
|
microtubule associated serine/threonine kinase 2
|
|
chr19_-_42463500
|
0.386
|
NM_006423
|
RABAC1
|
Rab acceptor 1 (prenylated)
|
|
chr19_+_12075868
|
0.386
|
NM_001012753
|
ZNF763
|
zinc finger protein 763
|
|
chr1_-_153508463
|
0.386
|
|
S100A6
|
S100 calcium binding protein A6
|
|
chr7_-_558810
|
0.385
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
chr15_-_75135524
|
0.382
|
NM_001099436
|
ULK3
|
unc-51-like kinase 3 (C. elegans)
|
|
chr1_+_9711781
|
0.380
|
NM_005026
|
PIK3CD
|
phosphoinositide-3-kinase, catalytic, delta polypeptide
|
|
chr15_+_41136178
|
0.373
|
NM_003710
NM_181642
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
chr20_+_61867234
|
0.371
|
NM_022161
NM_139317
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
chr3_-_57199402
|
0.371
|
NM_017563
|
IL17RD
|
interleukin 17 receptor D
|
|
chr9_+_4490193
|
0.365
|
NM_004170
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
chr3_+_50304989
|
0.362
|
NM_001005914
NM_004636
|
SEMA3B
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B
|
|
chr7_+_28448970
|
0.361
|
|
LOC401317
|
uncharacterized LOC401317
|
|
chr1_-_94375028
|
0.360
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
chr11_+_122526339
|
0.359
|
NM_032873
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
chr4_-_1166547
|
0.357
|
NM_012445
|
SPON2
|
spondin 2, extracellular matrix protein
|
|
chr20_+_361938
|
0.355
|
|
TRIB3
|
tribbles homolog 3 (Drosophila)
|
|
chr14_-_21493122
|
0.353
|
NM_201538
NM_201539
NM_201540
NM_201541
|
NDRG2
|
NDRG family member 2
|
|
chr1_+_26503973
|
0.350
|
NM_006314
|
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1
|
|
chr16_-_67193804
|
0.346
|
NM_003789
|
TRADD
|
TNFRSF1A-associated via death domain
|
|
chr1_+_19970674
|
0.342
|
NM_005380
|
NBL1
|
neuroblastoma, suppression of tumorigenicity 1
|
|
chr11_+_35160666
|
0.340
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
chr1_+_207495070
|
0.340
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
chr2_-_87088993
|
0.339
|
NM_001178100
NM_004931
NM_172101
NM_172102
NM_172213
|
CD8B
|
CD8b molecule
|
|
chr19_-_3606801
|
0.339
|
NM_001060
NM_201636
|
TBXA2R
|
thromboxane A2 receptor
|
|
chr5_+_69696805
|
0.337
|
|
SMA4
|
glucuronidase, beta pseudogene
|
|
chr5_-_146833150
|
0.337
|
NM_001387
|
DPYSL3
|
dihydropyrimidinase-like 3
|
|
chr3_+_194407412
|
0.336
|
|
FAM43A
|
family with sequence similarity 43, member A
|
|
chr4_+_154265841
|
0.334
|
|
MND1
|
meiotic nuclear divisions 1 homolog (S. cerevisiae)
|
|
chr10_-_30316338
|
0.333
|
|
KIAA1462
|
KIAA1462
|
|
chr1_-_167522979
|
0.332
|
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
chr11_-_124632050
|
0.331
|
NM_138961
|
ESAM
|
endothelial cell adhesion molecule
|
|
chr19_+_33166312
|
0.329
|
NM_207391
|
RGS9BP
|
regulator of G protein signaling 9 binding protein
|
|
chr6_+_33589045
|
0.329
|
NM_002224
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
chr11_-_66084501
|
0.328
|
NM_020404
|
CD248
|
CD248 molecule, endosialin
|
|
chr16_+_84002099
|
0.328
|
NM_019065
|
NECAB2
|
N-terminal EF-hand calcium binding protein 2
|
|
chr2_+_219187858
|
0.327
|
NM_022572
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
chr9_+_2622052
|
0.325
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
chr17_-_43510279
|
0.325
|
NM_174919
|
ARHGAP27
|
Rho GTPase activating protein 27
|
|
chr2_+_39103102
|
0.322
|
NM_001145450
|
MORN2
|
MORN repeat containing 2
|
|
chr5_-_179233772
|
0.322
|
NM_014275
|
MGAT4B
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B
|
|
chr20_-_62284701
|
0.318
|
NM_015894
|
STMN3
|
stathmin-like 3
|
|
chr9_+_2622099
|
0.318
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
chr19_-_49243836
|
0.317
|
NM_017805
|
RASIP1
|
Ras interacting protein 1
|
|
chr15_-_83621350
|
0.316
|
NM_004839
NM_199330
|
HOMER2
|
homer homolog 2 (Drosophila)
|
|
chr22_+_31478845
|
0.316
|
NM_001207017
|
SMTN
|
smoothelin
|
|
chr17_-_18950238
|
0.315
|
NM_006613
|
GRAP
|
GRB2-related adaptor protein
|
|
chr9_+_2622134
|
0.315
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
chr11_+_72983246
|
0.314
|
NM_004154
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
chr10_+_135192694
|
0.312
|
NM_152911
NM_207127
NM_207128
|
PAOX
|
polyamine oxidase (exo-N4-amino)
|
|
chr4_+_74702272
|
0.312
|
NM_002993
|
CXCL6
|
chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2)
|
|
chr16_+_4845265
|
0.312
|
NM_001253793
NM_001253794
|
LOC440335
|
uncharacterized LOC440335
|
|
chr1_+_86046434
|
0.311
|
NM_001554
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
chr2_-_27718098
|
0.311
|
NM_022823
|
FNDC4
|
fibronectin type III domain containing 4
|
|
chr16_-_81129882
|
0.309
|
NM_004483
|
GCSH
|
glycine cleavage system protein H (aminomethyl carrier)
|
|
chr2_-_42721083
|
0.309
|
NM_133329
NM_172344
|
KCNG3
|
potassium voltage-gated channel, subfamily G, member 3
|
|
chr12_+_53491448
|
0.308
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
chr16_-_2770551
|
0.308
|
NM_031948
|
PRSS27
|
protease, serine 27
|
|
chr1_+_16330730
|
0.306
|
NM_178840
|
C1orf64
|
chromosome 1 open reading frame 64
|
|
chr8_+_99439249
|
0.306
|
NM_020697
|
KCNS2
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2
|
|
chr14_-_65438794
|
0.305
|
NM_198686
|
RAB15
|
RAB15, member RAS onocogene family
|
|
chr11_-_790103
|
0.304
|
NM_016564
|
CEND1
|
cell cycle exit and neuronal differentiation 1
|
|
chr1_-_94374986
|
0.304
|
NM_002061
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
chr19_+_58694791
|
0.303
|
|
ZNF274
|
zinc finger protein 274
|
|
chr16_-_66959418
|
0.302
|
NM_001128850
NM_004165
|
RRAD
|
Ras-related associated with diabetes
|
|
chrX_-_49042845
|
0.302
|
|
PRICKLE3
|
prickle homolog 3 (Drosophila)
|
|
chr2_+_219187975
|
0.301
|
|
PNKD
|
paroxysmal nonkinesigenic dyskinesia
|
|
chr5_+_80529138
|
0.300
|
NM_001099735
NM_001099736
NM_001825
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
|
chr1_-_167523016
|
0.299
|
NM_003851
|
CREG1
|
cellular repressor of E1A-stimulated genes 1
|
|
chr17_+_16318911
|
0.298
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
chr20_+_51589752
|
0.297
|
|
TSHZ2
|
teashirt zinc finger homeobox 2
|
|
chr19_-_39227588
|
0.297
|
|
CAPN12
|
calpain 12
|
|
chr5_+_131593388
|
0.297
|
|
PDLIM4
|
PDZ and LIM domain 4
|
|
chr17_-_39684499
|
0.296
|
|
KRT19
|
keratin 19
|
|
chr7_-_100493481
|
0.295
|
NM_000665
NM_015831
|
ACHE
|
acetylcholinesterase
|
|
chr8_-_23261632
|
0.295
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
chr9_+_129724503
|
0.295
|
NM_001190728
|
RALGPS1
|
Ral GEF with PH domain and SH3 binding motif 1
|
|
chr9_+_139846767
|
0.294
|
NM_178536
|
LCN12
|
lipocalin 12
|
|
chr7_+_32767719
|
0.293
|
|
ZNRF2P1
|
zinc and ring finger 2 pseudogene 1
|
|
chr11_-_65487910
|
0.292
|
|
RNASEH2C
|
ribonuclease H2, subunit C
|
|
chr14_-_105647520
|
0.292
|
NM_177533
|
NUDT14
|
nudix (nucleoside diphosphate linked moiety X)-type motif 14
|
|
chr22_-_50708720
|
0.291
|
NM_002751
|
MAPK11
|
mitogen-activated protein kinase 11
|
|
chr1_-_94374949
|
0.291
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
chr20_+_35169897
|
0.290
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
chr8_+_16884745
|
0.290
|
NM_181723
|
EFHA2
|
EF-hand domain family, member A2
|
|
chr4_+_142557722
|
0.289
|
NM_000585
NM_172175
|
IL15
|
interleukin 15
|
|
chr11_+_94822937
|
0.289
|
NM_015036
|
ENDOD1
|
endonuclease domain containing 1
|
|
chr14_-_39901298
|
0.288
|
|
FBXO33
|
F-box protein 33
|
|
chr17_+_42836546
|
0.288
|
NM_002390
|
ADAM11
|
ADAM metallopeptidase domain 11
|
|
chr22_+_39417117
|
0.288
|
NM_152426
|
APOBEC3D
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D
|
|
chr2_-_85108238
|
0.287
|
NM_001080824
|
C2orf89
|
chromosome 2 open reading frame 89
|
|
chr15_-_71146427
|
0.286
|
NM_018357
NM_197958
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
chr1_-_40782826
|
0.285
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
chr11_-_61658853
|
0.285
|
NM_021727
|
FADS3
|
fatty acid desaturase 3
|
|
chr17_+_41363845
|
0.285
|
NM_145041
|
TMEM106A
|
transmembrane protein 106A
|
|
chr3_-_183145854
|
0.285
|
NM_015078
|
MCF2L2
|
MCF.2 cell line derived transforming sequence-like 2
|
|
chr11_-_74442429
|
0.285
|
|
CHRDL2
|
chordin-like 2
|
|
chr1_+_26644380
|
0.283
|
NM_001803
|
CD52
|
CD52 molecule
|
|
chr17_-_1012257
|
0.282
|
NM_001092
|
ABR
|
active BCR-related gene
|
|
chr17_-_17109630
|
0.282
|
NM_178836
|
PLD6
|
phospholipase D family, member 6
|
|
chr9_+_2621740
|
0.282
|
NM_001018056
NM_003383
|
VLDLR
|
very low density lipoprotein receptor
|
|
chr19_-_3600576
|
0.281
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
chr19_+_41223282
|
0.279
|
|
ITPKC
|
inositol-trisphosphate 3-kinase C
|
|
chr17_+_4802866
|
0.279
|
NM_001145536
|
C17orf107
|
chromosome 17 open reading frame 107
|
|
chr5_-_138718941
|
0.277
|
|
SLC23A1
|
solute carrier family 23 (nucleobase transporters), member 1
|
|
chr14_+_93118793
|
0.276
|
|
RIN3
|
Ras and Rab interactor 3
|
|
chr1_+_168545710
|
0.275
|
NM_002995
|
XCL1
|
chemokine (C motif) ligand 1
|
|
chr6_-_99797530
|
0.272
|
NM_032511
|
C6orf168
|
chromosome 6 open reading frame 168
|
|
chr4_-_1166458
|
0.272
|
|
SPON2
|
spondin 2, extracellular matrix protein
|
|
chr1_-_16399936
|
0.272
|
NM_182623
|
FAM131C
|
family with sequence similarity 131, member C
|
|
chr9_+_101569933
|
0.272
|
NM_024642
|
GALNT12
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12)
|
|
chr19_+_16178170
|
0.269
|
NM_001145160
|
TPM4
|
tropomyosin 4
|
|
chr19_-_42463437
|
0.267
|
|
RABAC1
|
Rab acceptor 1 (prenylated)
|
|
chr7_+_45927958
|
0.266
|
NM_000596
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
chr19_+_46001730
|
0.266
|
NM_001080401
|
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative)
|
|
chr1_-_168105620
|
0.265
|
NM_153832
|
GPR161
|
G protein-coupled receptor 161
|
|
chr3_-_189838673
|
0.265
|
|
LEPREL1
|
leprecan-like 1
|
|
chr8_-_109799769
|
0.265
|
NM_153015
|
TMEM74
|
transmembrane protein 74
|
|
chr9_-_140317583
|
0.265
|
|
EXD3
|
exonuclease 3'-5' domain containing 3
|
|
chr2_-_87248942
|
0.264
|
NM_002665
NM_001032392
|
PLGLB2
PLGLB1
|
plasminogen-like B2
plasminogen-like B1
|
|
chr3_+_33318911
|
0.264
|
NM_012157
NM_001171713
|
FBXL2
|
F-box and leucine-rich repeat protein 2
|
|
chr2_-_24307179
|
0.261
|
NM_001206802
|
TP53I3
|
tumor protein p53 inducible protein 3
|
|
chr16_+_15528324
|
0.260
|
NM_033201
|
C16orf45
|
chromosome 16 open reading frame 45
|
|
chr10_-_82116499
|
0.259
|
NM_138812
|
DYDC1
|
DPY30 domain containing 1
|
|
chr9_+_139971938
|
0.259
|
NM_207309
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1
|
|
chrX_-_49042741
|
0.257
|
NM_006150
|
PRICKLE3
|
prickle homolog 3 (Drosophila)
|
|
chr2_+_220492286
|
0.257
|
NM_005070
NM_201574
|
SLC4A3
|
solute carrier family 4, anion exchanger, member 3
|
|
chr4_-_683107
|
0.256
|
|
MFSD7
|
major facilitator superfamily domain containing 7
|
|
chr16_-_30582951
|
0.256
|
|
ZNF688
|
zinc finger protein 688
|
|
chr13_+_96204941
|
0.255
|
NM_006984
|
CLDN10
|
claudin 10
|
|
chr13_+_21277481
|
0.255
|
NM_138284
|
IL17D
|
interleukin 17D
|
|
chr20_+_43803539
|
0.254
|
NM_002638
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
chr12_-_6745087
|
0.254
|
NM_020400
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
chr16_+_68771304
|
0.253
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
chr14_-_77965100
|
0.253
|
NM_182509
NM_199296
|
ISM2
|
isthmin 2 homolog (zebrafish)
|
|
chr4_+_77227882
|
0.252
|
|
STBD1
|
starch binding domain 1
|
